Shoreline Biosciences showcases novel methodology to produce clinical scale iPSC-derived NK (iNK) cells
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
The investment of around €7 million significantly enhances the site’s flexibility and capacity in synthesizing modern, complex and even corrosive molecules
Both companies have been selected for stand-by production by German government
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
Ideal power boosters to strengthen muscles and keep energised for all kinds of physical activities
Lidocaine and Prilocaine Cream USP, 2.5%/2.5% has an estimated market size of US $ 29 million for twelve months ending Dec. 2021 according to IQVIA
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
Subscribe To Our Newsletter & Stay Updated